Skip to main content

Advertisement

SpringerLink
Log in

Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Neurturin (NTN) is a member of the glial cell line-derived neurotrophic factor (GDNF) family; and, while GDNF has been shown to increase dopamine (DA) release in normal animals, the ability of NTN to alter DA release has not been previously reported. The purpose of the present study was to determine if NTN could alter striatal DA release, and to compare the effects of NTN to GDNF. Male Fischer-344 rats were given a single injection of vehicle or 5 μg NTN or GDNF into the right substantia nigra. Three weeks later microdialysis experiments were conducted to assess striatal DA release. Basal extracellular levels of striatal DA were not affected by either NTN or GDNF. However, both NTN and GDNF led to increases in amphetamine-evoked overflow of DA from the ipsilateral striatum, and there was a trend for potassium-evoked overflow to be augmented. Postmortem tissue levels of DA were decreased by approximately 20% in the striatum, and increased by approximately 100% in the substantia nigra, on the ipsilateral side of the brain compared to the contralateral side following both NTN and GDNF injection. Thus, NTN, like GDNF, can augment striatal DA release, and the magnitude of the NTN effects are similar to those of GDNF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Hudson J, Granholm A-C, Gerhardt GA et al (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36:425–432

    Article  CAS  PubMed  Google Scholar 

  2. Martin D, Miller G, Cullen T et al (1996) Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats. Eur J Pharmacol 317:247–256

    Article  CAS  PubMed  Google Scholar 

  3. Hebert MA, Van Horne CG, Hoffer BJ et al (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther 279:1181–1190

    CAS  PubMed  Google Scholar 

  4. Xu K, Dluzen DE (2000) The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K+ stimulation. Exp Neurol 166:450–457

    Article  CAS  PubMed  Google Scholar 

  5. Rosenblad C, Georgievska B, Kirik D (2003) Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur J Neurosci 17:260–270

    Article  PubMed  Google Scholar 

  6. Salvatore MF, Zhang J-L, Large DM et al (2004) Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J Neurochem 90:245–254

    Article  CAS  PubMed  Google Scholar 

  7. Kobayashi S, Ogren SO, Hoffer BJ et al (1998) Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum. Exp Neurol 154:302–314

    Article  CAS  PubMed  Google Scholar 

  8. Emerich DF, Plone M, Francis J et al (1996) Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res 736:99–110

    Article  CAS  PubMed  Google Scholar 

  9. Hebert MA, Gerhardt GA (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 282:760–768

    CAS  PubMed  Google Scholar 

  10. Lapchak PA, Miller PJ, Jiao S (1997) Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats. Neuroscience 77:745–752

    Article  CAS  PubMed  Google Scholar 

  11. Grondin R, Cass WA, Zhang Z et al (2003) Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J Neurosci 23:1974–1980

    CAS  PubMed  Google Scholar 

  12. Kotzbauer PT, Lampe PA, Heuckeroth RO et al (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384:467–470

    Article  CAS  PubMed  Google Scholar 

  13. Horger BA, Nishimura MC, Armanini MP et al (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18:4929–4937

    CAS  PubMed  Google Scholar 

  14. Akerud P, Alberch J, Eketjall S et al (1999) Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 73:70–78

    Article  CAS  PubMed  Google Scholar 

  15. Zihlmann KB, Ducray AD, Schaller B et al (2005) The GDNF family members neurturin, artemin and persephin promote the morphological differentiation of cultured ventral mesencephalic dopaminergic neurons. Brain Res Bull 68:42–53

    Article  CAS  PubMed  Google Scholar 

  16. Hoane MR, Gulwadi AG, Morrison S et al (1999) Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor. Exp Neurol 160:235–243

    Article  CAS  PubMed  Google Scholar 

  17. Hamilton JF, Morrison PF, Chen MY et al (2001) Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp Neurol 168:155–161

    Article  CAS  PubMed  Google Scholar 

  18. Moghaddam B, Bunney BS (1989) Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem 53:652–654

    Article  CAS  PubMed  Google Scholar 

  19. Cass WA, Harned ME, Peters LE et al (2003) HIV-1 protein tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Res 984:133–142

    Article  CAS  PubMed  Google Scholar 

  20. Glick SD, Dong N, Keller RW Jr et al (1994) Estimating extracellular concentrations of dopamine and 3, 4-dihydroxyphenylacetic acid in nucleus accumbens and striatum using microdialysis: relationships between in vitro and in vivo recoveries. J Neurochem 62:2017–2021

    Article  CAS  PubMed  Google Scholar 

  21. Cass WA, Manning MW (1999) GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine. J Neurosci 19:1416–1423

    CAS  PubMed  Google Scholar 

  22. Pothos EN, Davila V, Sulzer D (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J Neurosci 18:4106–4118

    CAS  PubMed  Google Scholar 

  23. Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331–349

    Article  CAS  PubMed  Google Scholar 

  24. Wood PL, Alter CA (1988) Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol Rev 40:163–187

    CAS  PubMed  Google Scholar 

  25. Zetterstrom T, Sharp T, Collin AK et al (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148:327–334

    Article  CAS  PubMed  Google Scholar 

  26. Salvatore MF, Gerhardt GA, Dayton RD et al (2009) Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system. Exp Neurol 219:197–207

    Article  CAS  PubMed  Google Scholar 

  27. Robertson GS, Robertson HA (1989) Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326–3331

    CAS  PubMed  Google Scholar 

  28. Trevitt JT, Carlson BB, Nowend K et al (2001) Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology 156:32–41

    Article  CAS  PubMed  Google Scholar 

  29. Gerhardt GA, Cass WA, Yi A et al (2002) Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys. J Neurochem 80:168–177

    Article  CAS  PubMed  Google Scholar 

  30. Hoffman AF, Van Horne CG, Eken S et al (1997) In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp Neurol 147:130–147

    Article  CAS  PubMed  Google Scholar 

  31. Baloh RH, Enomoto H, Johnson EM Jr et al (2000) The GDNF family ligands and receptors–implications for neural development. Curr Opin Neurobiol 10:103–110

    Article  CAS  PubMed  Google Scholar 

  32. Airaksinen MS, Saarma M (2002) The GDNF family: signaling, biological functions and therapeutic value. Nat Rev Neurosci 3:383–394

    Article  CAS  PubMed  Google Scholar 

  33. Widenfalk J, Nosrat C, Tomac A et al (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-ß (GDNFR-ß), novel proteins related to GDNF and GDNFR-α with specific cellular patters of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci 17:8506–8519

    CAS  PubMed  Google Scholar 

  34. Golden JP, Baloh RH, Kotzbauer PT et al (1998) Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J Comp Neurol 398:139–150

    Article  CAS  PubMed  Google Scholar 

  35. Burazin TCD, Gundlach AL (1999) Localization of GDNF/neurturin receptor (c-ret, GFRα-1 and α-2) mRNAs in postnatal rat brain: differential regional and temporal expression in hippocampus, cortex and cerebellum. Mol Brain Res 73:151–171

    Article  CAS  PubMed  Google Scholar 

  36. Kozlowski DA, Miljan EA, Bremer EG et al (2004) Quantitative analysis of GFRα-1 and GFRα-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. Brain Res 1016:170–181

    Article  CAS  PubMed  Google Scholar 

  37. Rosenblad C, Kirik D, Devaux B et al (1999) Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson’s disease after administration into the striatum or the lateral ventricle. Eur J Neurosci 11:1554–1566

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by United States Public Health Service Grant AG17963.

Author information

Authors and Affiliations

  1. Department of Anatomy and Neurobiology, MN-225 Chandler Medical Center, University of Kentucky College of Medicine, Lexington, KY, 40536-0298, USA

    Wayne A. Cass & Laura E. Peters

Authors
  1. Wayne A. Cass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura E. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wayne A. Cass.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cass, W.A., Peters, L.E. Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF. Neurochem Res 35, 727–734 (2010). https://doi.org/10.1007/s11064-010-0128-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-010-0128-0

Keywords

Search

Navigation